Last updated: July 17, 2026

Application No. 18/687,030

SPATIAL MULTIOMICS USING IN SITU REVERSE TRANSCRIPTION

Non-Final OA

Filed

Feb 27, 2024

Priority

Sep 01, 2021 — provisional 63/239,897 +1 more

Examiner

POHNERT, STEVEN C

Art Unit

Tech Center

Assignee

Becton, Dickinson and Company

OA Round

1 (Non-Final)

This examiner grants 12% of cases after interview

— +18.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 865 resolved cases, 2023–2026

Examiner Intelligence

POHNERT, STEVEN C View full profile →

Grants only 12% of cases

Career Allowance Rate

106 granted / 865 resolved

-47.7% vs TC avg

Strong +19% interview lift

Without

With

+18.6%

Interview Lift

resolved cases with interview

Typical timeline

4y 2m

Avg Prosecution

58 currently pending

Career history

944

Total Applications

across all art units

Statute-Specific Performance

§101

6.1%

-33.9% vs TC avg

§103

60.0%

+20.0% vs TC avg

§102

7.6%

-32.4% vs TC avg

§112

6.6%

-33.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 865 resolved cases

Prosecution Timeline

Feb 27, 2024

Application Filed

Apr 28, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/922,962

Patent 12577586

CROSS-SPECIES COMPATIBLE ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS OF USE THEREOF

3y 4m to grant Granted Mar 17, 2026

16/896,118

Patent 12559788

Multiple Beads Per Droplet Resolution

5y 8m to grant Granted Feb 24, 2026

17/816,988

Patent 12460251

STABILIZATION AND/OR COMPACTION OF NUCLEIC ACID MOLECULES

3y 3m to grant Granted Nov 04, 2025

17/816,985

Patent 12391984

COMPOSITIONS AND METHODS FOR ROLLING CIRCLE AMPLIFICATION

3y 0m to grant Granted Aug 19, 2025

16/379,260

Patent 12286675

Epigentic Markers for the Identification of Blood Sub-cells of Type 1

6y 0m to grant Granted Apr 29, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

12%

Grant Probability

31%

With Interview (+18.6%)

4y 2m (~1y 9m remaining)

Median Time to Grant

Low

PTA Risk

Based on 865 resolved cases by this examiner. Grant probability derived from career allowance rate.